Permanent birth control method may place patients in danger

Patients understandably trust their physicians to recommend treatment plans which will ultimately work to improve their medical conditions as opposed to negatively impact them. Unfortunately, some dangerous treatments remain on the market even after patients and physicians alike have reported that these treatments can be far more hazardous than beneficial.

For example, a number of women is currently attempting to persuade the U.S. Food and Drug Administration to take a permanent birth control method called Essure off the market. The women have used social media to educate the public about potential hazards associated with this medical device and they were ultimately allowed to voice their concerns directly to the FDA.

This device can allegedly cause women devastating complications. In addition, concerns remain that problems with the testing phase of this device’s approval process should have rendered it unsafe to market.

The story of the Essure device is not unique. Many prescription medications, medical devices, tests and treatments ultimately harm numerous patients before the safety hazards associated with them are properly evaluated. As a result, it is up to patients to remain as informed as possible about the various treatments that are recommended to them. It is also up to physicians to remain educated in order to better ensure that they are not recommending defective or unreasonably dangerous drugs, devices and treatments for their patients.

If physicians either know or strongly suspect that a given treatment may unreasonably harm a patient and recommends this course of treatment anyway without educating the patient about the risks involved, the patient may choose to sue that physician if harm results from the recommended treatment.

Source: WJLA, “Women share concerns about permanent birth control device with FDA,” Joce Sterman, April 2, 2015



Click on the button below to fill out our free initial consultation form and one of our team members will reach out to gather more information.

    • Please enter your name.
    • This isn't a valid phone number.
      Please enter your phone number.
    • This isn't a valid email address.
      Please enter your email address.
    • Please make a selection.
    • Please enter a message.